Replies to post #384929 on Anavex Life Sciences Corp (AVXL)

[Jonjones325]

I guess it depends who you ask.

Missling getting the blank check preferreds years ago shows how far ahead he was thinking.

Imagine how far ahead in his planning he is now. He’s already been saying prophylactic for years. And just said they we’re scratching the surface with our platform.

He was already talking to Rett partners in Asia. This is a man with a clear plan and vision.

All his minor blunders will soon be forgotten and forgiven.

[growingpain]

It is likely that they missed the original endpoints of the PDD trial and the AVATAR trial. However, both of the trials were modified and they are now considered successful. The PDD trial became a proof-of-concept trial with objectives instead of endpoints and under this label the results are very good. The AVATAR trial had new endpoints and became P3 a few weeks before the readout. The new endpoints were met but the original ones were never reported.